Skip to search formSkip to main contentSkip to account menu

Bextra

Known as: Pfizer brand of valdecoxib 
a kind of nonsteroidal anti-inflammatory drugs
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

valdecoxib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Food and Drug Administration Regulation of Drugs That Raise Blood Pressure
Although it is recognized that a systolic blood pressure (SBP) increase ≥2 mm Hg or a diastolic blood pressure (DBP) increase ≥1… 
2012
2012
Legal and Economic Perspectives Concerning US Government Investigations of Alleged Off-Label Promotion by Drug Manufacturers
Over the past few years, many pharmaceuticalmanufacturers have settled claims brought bythe US Department of Justice (USDOJ… 
2009
2009
Pfizer settles largest ever fraud suit for off-label promotion
2008
2008
Scientists consider meat pie mammography and self heating bathtubs
The economic and humanitarian situation in Gaza is worse now than at any time since Israel occupied the area in 1967, claims a… 
Highly Cited
2005
Highly Cited
2005
Parecoxib, valdecoxib, and cardiovascular risk.
Selective inhibitors of cyclooxygenase (COX)-21 depress prostacyclin (PGI2) but not COX-1–derived thromboxane A2. The effects of… 
Review
2005
Review
2005
Selective Cyclooxygenase-2 Inhibitors Development in Cardiovascular Medicine
At the end of September 2004, Merck & Co announced the voluntary withdrawal of rofecoxib (Vioxx) worldwide because of an… 
2005
2005
Vioxx Verdict: Too Little or Too Much Science?
THE LAWA widow's victory in the first of thousands of cases against Merck's pain reliever sidesteps important questions about the… 
2005
2005
Speech transcript stokes opposition to Harvard head
University president Larry Summers under fire for remarks on women in science. 
Review
2005
Review
2005
Pfizer withdraw valdecoxib (Bextra) at Health Canada's request
  • B. Sibbald
  • Canadian Medical Association Journal
  • 2005
  • Corpus ID: 71130581
that Pfizer Canada has voluntarily withdrawn valdecoxib (Bextra) from the market pending the resolution of safety issues. Health… 
2005
2005
Bextra Withdrawn From Market
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)